BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Neurology

NeuroAiD has shown favourable outcome in patients suffering from spinal cord injuries

NeuroAiD was safe as add-on treatment in patients with severe SCI. One third of patients improved on ASIA Impairment Scale (AIS) grading with ...

June 07, 2022 | News

Aruna Bio Advances Therapeutic Development for Traumatic Brain Injury

"The successful completion of the proposed study is intended to provide key information pertaining to AB126™ dosage, and therapeutic effects on T...

June 01, 2022 | News

Changes in brain's visual areas in infancy may precede autism diagnosis

WHAT:Infants who were diagnosed with autism spectrum disorder (ASD) at 24 months old had differences in the visual processing areas of the brain that were ...

May 30, 2022 | News

Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion

The acquisition is one of the largest cross-border transactions in the medical device industry globally in recent years and is driven by strong growth oppo...

April 22, 2022 | News

TauRx's late-stage clinical trial reaches new milestone

TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last patient has completed treatment in t...

April 14, 2022 | News

NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today announced tha...

March 22, 2022 | News

Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals

These deuterated compounds represent next-generation therapeutics with applications across several different psychiatric and neurological conditions. Terra...

March 13, 2022 | News

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...

March 03, 2022 | News

BioMed X Institute and Boehringer Ingelheim Start New Research Project in Brain Sensor Development

German independent research institute BioMed X announces today the start of its new research project ‘Advanced Biomarker Detection for Phar...

March 01, 2022 | News

Clarity advances to cohort 2 in the SARTATE™ neuroblastoma trial

No dose limiting toxicities (DLTs) have been reported in cohort 1 - The Safety Review Committee (SRC) has recommended the trial continues with the d...

February 02, 2022 | News

HMI Group Strengthens Specialist Offering, Acquires Majority Stake in Eagle Eye Centre

Health Management International Pte Ltd (HMI Group), a growing regional private healthcare provider with presence in Singapore, Malaysia and Indonesia, has...

January 25, 2022 | News

Medtronic announces FDA approval of spinal cord stimulation therapy

Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management...

January 25, 2022 | News

Eppendorf & Science Prize for Neurobiology 2022 Call for Entries!

This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based ...

January 19, 2022 | News

SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease

ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a pro...

January 12, 2022 | News

Stay Connected